Castle Biosciences, Inc. - Special Call Transcript
Good afternoon, and welcome to Castle Biosciences DecisionDx DiffDx-Melanoma investor webcast and conference call. As a reminder, today's call is being recorded. (Operator Instructions)
I would like to turn the call over to Derek Maetzold, President and CEO. Please go ahead.
Thank you, operator. Good afternoon, everyone. Welcome to Castle Biosciences DecisionDx DiffDx-Melanoma investor webcast and conference call.
As most presentations, the following discussion contains forward-looking statements, and our actual results may differ materially from those discussed here. Additional information concerning factors that could cause such a difference can be found in the disclaimer slide included in the presentation and the company's quarterly report on Form 10-Q for the quarter ended June 30, 2020, and the annual report on Form 10-K for the year ended December 31, 2019.
We have a fairly packed agenda this afternoon. I will open up and set the table of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
